United Health Products, Inc. Files Q3 2024 10-Q

TL;DR

**UHP filed its Q3 2024 10-Q. Check financials.**

AI Summary

United Health Products, Inc. filed its 10-Q for the period ending September 30, 2024. The company, previously known as United EcoEnergy Corp., is based in Mesquite, NV and operates in the orthopedic, prosthetic & surgical appliances & supplies industry. Financial details for the period are not explicitly detailed in this header information, but the filing covers the third quarter of 2024.

Why It Matters

This filing provides an update on United Health Products, Inc.'s financial performance and operational status for the third quarter of 2024, which is crucial for investors and stakeholders to assess the company's current standing.

Risk Assessment

Risk Level: medium — The filing is a standard quarterly report, but the limited specific financial data provided in the header and the company's history of name changes suggest potential areas for further investigation.

Key Numbers

• 20240930 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
• 20241112 — Filing Date (Shows when the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• United Health Products, Inc. (company) — Filer
• 0001096938 (company) — Central Index Key
• Mesquite, NV (location) — Business Address
• United EcoEnergy Corp. (company) — Former Company Name

FAQ

Key Financial Figures

• $0.35 — rity date at a price that is lower than $0.35 per share, the conversion price shall b
• $0 — remaining unamortized debt discount was $0, respectively. Accrued interest associa

Filing Documents

• ueec_10q.htm (10-Q) — 754KB
• ueec_ex311.htm (EX-31.1) — 11KB
• ueec_ex312.htm (EX-31.2) — 9KB
• ueec_ex321.htm (EX-32.1) — 5KB
• ueec_ex322.htm (EX-32.2) — 5KB
• 0001477932-24-007039.txt ( ) — 3215KB
• ueec-20240930.xsd (EX-101.SCH) — 34KB
• ueec-20240930_lab.xml (EX-101.LAB) — 216KB
• ueec-20240930_cal.xml (EX-101.CAL) — 35KB
• ueec-20240930_pre.xml (EX-101.PRE) — 173KB
• ueec-20240930_def.xml (EX-101.DEF) — 91KB
• ueec_10q_htm.xml (XML) — 331KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Condensed Balance Sheets as of September 30, 2024 (unaudited) and December 31, 2023 3 Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2024 and September 30, 2023 (unaudited) 4 Condensed Statement of Stockholders' Deficiency for the Three and Nine Months Ended September 30, 2024 and September 30, 2023 (unaudited) 5 Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2024 and September 30, 2023 (unaudited) 7 Notes to Condensed Financial Statements (unaudited) 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures

Quantitative and Qualitative Disclosures 24 Item 4.

Controls and Procedures

Controls and Procedures 24

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 25 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25 Item 3. Defaults Upon Senior Securities 25 Item 4. Mine Safety Disclosures 25 Item 5. Other Information 25 Item 6. Exhibits 27

SIGNATURES

SIGNATURES 29 2 Table of Contents UNITED HEALTH PRODUCTS, INC. Condensed Balance Sheets September 30, December 31, 2024 2023 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 43,783 $ 95,420 Inventory - 33,598 Prepaid and other current assets 19,908 22,804 Total current assets 63,691 151,822 Deferred offering costs - 21,051 Operating lease right-of-use asset 54,726 76,520 Security deposit 2,850 2,850 Patents, net 29,362 32,400 TOTAL ASSETS $ 150,629 $ 284,643 Current Liabilities Accounts payable and accrued expenses $ 926,603 $ 987,567 Accrued liabilities - related parties 421,668 226,475 Operating lease liability - current 29,640 28,838 Notes payable 150,000 - Convertible notes payable, net of debt discount 207,500 207,500 Convertible notes payable – related party, net of debt discount 500,000 500,000 Total current liabilities 2,235,411 1,950,380 Operating lease liability – long-term 26,475 48,489 TOTAL LIABILITIES 2,261,886 1,998,869 Commitments and Contingencies - - Stockholders' Deficit Series A Convertible Preferred Stock - $ 0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding - - Common Stock - $ 0.001 par value, 300,000,000 shares Authorized, 249,633,222 and 244,783,222 shares issued and outstanding at September 30, 2024 and December 31, 2023 249,633 244,783 Additional Paid-In Capital 75,525,941 74,740,201 Accumulated Deficit ( 77,886,831 ) ( 76,699,210 ) Total Stockholders' Deficit ( 2,111,257 ) ( 1,714,226 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 150,629 $ 284,643 See notes to unaudited condensed financial statements. 3 Table of Contents UNITED HEALTH PRODUCTS, INC. Condensed Statements of Operations (Unaudited) For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenues $ - $

View Full Filing

View this 10-Q filing on SEC EDGAR